Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Antacid Market, by Region, 2017-2026 (USD Billion)
1.2.2. Antacid Market, by Drug Class, 2017-2026 (USD Billion)
1.2.3. Antacid Market, by Formulation, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Antacid Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Antacid Market Dynamics
3.1. Antacid Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Antacid Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Antacid Market, by Drug Class
5.1. Market Snapshot
5.2. Antacid Market by Drug Class, Performance - Potential Analysis
5.3. Antacid Market Estimates & Forecasts by Drug Class 2016-2026 (USD Billion)
5.4. Polymer Emulsion Market, Sub Segment Analysis
5.4.1. H2 Antagonist
5.4.2. Proton pump inhibitors
5.4.3. Acid neutralizers
Chapter 6. Antacid Market, by Formulation
6.1. Market Snapshot
6.2. Antacid Market by Formulation, Performance - Potential Analysis
6.3. Antacid Market Estimates & Forecasts by Formulation 2016-2026 (USD Billion)
6.4. Polymer Emulsion Market, Sub Segment Analysis
6.4.1. Tablet
6.4.2. Liquid
6.4.3. Powder
Chapter 7. Antacid Market, Regional Analysis
7.1. Antacid Market, Regional Market Snapshot
7.2. North America Antacid Market
7.2.1. U.S. Antacid Market
7.2.1.1. Drug Class breakdown estimates & forecasts, 2016-2026
7.2.1.2. Formulation breakdown estimates & forecasts, 2016-2026
7.2.2. Canada Antacid Market
7.3. Europe Antacid Market Snapshot
7.3.1. U.K. Antacid Market
7.3.2. Rest of Europe Antacid Market
7.4. Asia-Pacific Antacid Market Snapshot
7.4.1. China Antacid Market
7.4.2. India Antacid Market
7.4.3. Japan Antacid Market
7.4.4. Rest of Asia Pacific Antacid Market
7.5. Latin America Antacid Market Snapshot
7.5.1. Brazil Antacid Market
7.5.2. Mexico Antacid Market
7.6. Rest of The World Antacid Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. GlaxoSmithKline plc
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Bayer AG
8.2.3. Boehringer Ingelheim International GmbH
8.2.4. Sanofi
8.2.5. Pfizer Inc.
8.2.6. Abbott Laboratories
8.2.7. Dabur India Ltd.
8.2.8. GlaxoSmithKline plc
8.2.9. Sun Pharmaceuticals Ltd.
8.2.10. Procter & Gamble
8.2.11. Piramal Enterprises
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption